VIM and colorectal carcinoma: DNA methylation markers (vimentin, septin 9, p16, APC, mutL homolog 1, and death-associated protein kinase 1), involving epigenetic modifications of DNA molecules, can provide insights into the epigenetic changes implicated in CRC development and progression.